Invesco
PCVX icon

Invesco’s Vaxcyte PCVX Stock Holding History

Invesco’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Sell
173,439
-10,604
-6% -$576K ﹤0.01% 1893
2026
Q1 		$10.7M Buy
184,043
+42,823
+30% +$2.32M ﹤0.01% 1793
2025
Q4 		$6.52M Sell
141,220
-37,861
-21% -$1.69M ﹤0.01% 2104
2025
Q3 		$6.45M Buy
179,081
+17,445
+11% +$578K ﹤0.01% 2100
2025
Q2 		$5.25M Sell
161,636
-1,094,191
-87% -$35.9M ﹤0.01% 2165
2025
Q1 		$47.4M Buy
1,255,827
+89,773
+8% +$7.18M 0.01% 1057
2024
Q4 		$95.5M Sell
1,166,054
-146,042
-11% -$14.5M 0.02% 828
2024
Q3 		$150M Buy
1,312,096
+233,376
+22% +$21M 0.03% 691
2024
Q2 		$81.5M Sell
1,078,720
-155,789
-13% -$10.6M 0.02% 841
2024
Q1 		$84.3M Buy
1,234,509
+1,007,558
+444% +$69.8M 0.02% 835
2023
Q4 		$14.3M Buy
226,951
+75,386
+50% +$3.92M ﹤0.01% 1599
2023
Q3 		$7.73M Sell
151,565
-86,574
-36% -$4.27M ﹤0.01% 1930
2023
Q2 		$11.9M Buy
238,139
+198,671
+503% +$9.42M ﹤0.01% 1688
2023
Q1 		$1.48M Sell
39,468
-180,771
-82% -$7.67M ﹤0.01% 2756
2022
Q4 		$10.6M Buy
220,239
+184,189
+511% +$7.23M ﹤0.01% 1803
2022
Q3 		$864K Sell
36,050
-1,546
-4% -$39.2K ﹤0.01% 2981
2022
Q2 		$818K Buy
37,596
+10,407
+38% +$241K ﹤0.01% 3080
2022
Q1 		$656K Buy
27,189
+12,719
+88% +$278K ﹤0.01% 3266
2021
Q4 		$344K Sell
14,470
-2,188
-13% -$50.9K ﹤0.01% 3556
2021
Q3 		$423K Buy
16,658
+2,095
+14% +$50.8K ﹤0.01% 3505
2021
Q2 		$328K Buy
+14,563
New +$298K ﹤0.01% 3594

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Invesco's PCVX Position: Q2 2026 in Review

Invesco reduced its Vaxcyte (PCVX) stake by 5.8% in Q2 2026, selling an estimated $576K and leaving 173,439 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Invesco first reported a position in PCVX in Q2 2021 and has held it in 21 quarters since. The position peaked at $150M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Invesco held 173,439 shares of Vaxcyte worth $10.1M as of Q2 2026.
  • Invesco sold 10,604 Vaxcyte shares in Q2 2026, an estimated $576K.
  • Vaxcyte made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1893 holding.
  • Invesco first reported a position in Vaxcyte in Q2 2021 and has held it in 21 quarters since.
  • Invesco's Vaxcyte position peaked at $150M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.